Skip to main content
Premium Trial:

Request an Annual Quote

Patrice Hugo, David Weber

Premium
MDS Pharma Services has named Patrice Hugo as vice president of scientific affairs for its global central lab network, the company announced this week.
 
In this role, Hugo will lead the development of biomarkers and assays to enhance clinical development productivity from Phases I through IV.
 
Hugo was previously executive vice president of research and development at Caprion Proteomics. From 1997 to 2003, he was vice president of scientific research and then chief scientific officer at Procrea BioSciences. Prior to Procrea, Hugo worked for the Institut de Recherches Cliniques de Montreal (Montreal Institute of Clinical Research).
 


 
Fluorotechnics has named former GE Healthcare Biosciences President David Weber as non-executive director.
 
Weber was most recently chief executive officer and president of Eksigent Technologies. Prior to Ekisigent, he was the vice president of global marketing and business development for Stratagene.
 
Weber has also held senior executive roles with Chemdex, Amersham Biosciences, and Pharmacia Biotech.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.